Multiple insider sales at Mirum Pharmaceuticals raises potential investor concern, despite insider purchase by CFO displaying some confidence in the firm's future. Notably, insider ownership indicates alignment between management and smaller shareholders.
Mirum Pharmaceuticals' muted future revenue growth compared to broader industry may struggle to support its current P/S ratio. The modest growth could potentially drag down shares despite maintaining current prices.
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week. Top Medical News of the Week Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and r...
$凯利服务-A(KELYA.US)$$百事可乐(PEP.US)$$Mirum Pharmaceuticals(MIRM.US)$On CNBC’s "Mad Money Lightning Round," Jim Cramer said Kelly Services, Inc. is a "very well-run company. Right now, with people just feeling it’s easy to get a job, you don’t need them. That’s why that stock has been such a dog. You never know, but I am not a buyer of it right here, though." When asked about PepsiCo, Inc. , Cram...
Gainers: •$梅西百货(M.US)$+13.2% (Macy's posts strong sales growth and raises earnings outlook) •$美元树公司(DLTR.US)$+12.7% (In reaction to earnings) •$美国达乐公司(DG.US)$+11.1% (Dollar Gen beat estimated earnings by 3.88%, reporting an EPS of $2.41 versus an estimate of $2.32.) •$Williams-Sonoma(WSM.US)$+8.4% (In reaction to earnings) •$Akoustis Technologies(AKTS.US)$+6.1% (suspended sales under its previously-announced "...
lightfoot :
Bpu will I see 34. made over $580. from 9 to 32. Thanks Peabody waiting on earnings report. hope to profit s thousand at least. by low sell high
SpyderCall : Very valuable info as usual. Thanks for the hard work.
shintaka1168 : こんな情報を配信してくれるなんて、おどろきました。これからもチェックしようと思います